Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised,Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Diltiazem Hydrochloride Cream in Subjects With Anal Fissure

NCT01217515 is registered in ClinicalTrials.gov with S.L.A. Pharma AG as lead sponsor.

NCT NCT01217515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01217515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised,Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Diltiazem Hydrochloride Cream in Subjects With Anal Fissure
Lead sponsor
S.L.A. Pharma AG
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2010
Completion date
May 31, 2012
Enrollment
465 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

chronic anal fissure